MEDINET Co., Ltd. operates as a contract development and manufacturing organization that provides regenerative medicine and cell therapy solutions in Japan. It operates through two segments: Cell Processing Business and Regenerative Medicine Products Business.The company's solutions include technical know-how, facilities, systems, materials, professional cell-engineers, and other requirements to conduct immuno-cell therapy.It also manufactures regenerative medical/investigational and specified cell products. In addition, the company offers value chain solutions, such as personnel training, facility and equipment design, facility operations and management, preparation of standard operating procedures, logistics network, information system, purchasing and production management, quality management system, quality control and assurance, and technology transfer and process development solutions. The company serves medical institutions, research institutions, and biopharmaceutical companies. MEDINET Co., Ltd. was incorporated in 1995 and is headquartered in Tokyo, Japan.
Часто задаваемые вопросы
В каком секторе работает Medinet Co Ltd (2370)?
Medinet Co Ltd относится к сектору Здравоохранение.
Какова текущая цена акций Medinet Co Ltd (2370)?
По последним данным, цена акций Medinet Co Ltd составляет 24 ¥, предыдущее закрытие — 24 ¥.
Выплачивает ли Medinet Co Ltd (2370) дивиденды?
Нет, Medinet Co Ltd не выплачивает дивиденды.
Какой бета-коэффициент (волатильность) у Medinet Co Ltd (2370)?
У компании Medinet Co Ltd бета 0.416, что указывает на более низкую волатильность по сравнению с рынком в целом.